Heparin and Bleeding: An Association with Lipase Release

Summary

The effects of four sulphated polysaccharides on bleeding time and lipase release in rabbits have been compared. Unfractionated heparin (UFH) and pentosan polysulphate both gave significant prolongation of bleeding times and high lipase release. Low molecular weight heparin had reduced effects on bleeding time and lipase release, while demialan sulphate had no influence on either parameter. There was a highly significant correlation (r = 0.97) between these two measurements.

These results suggest that the same structural featuresinfluence both the haemorrhagic and lipase-releasing properties of sulphated polysaccharides.

Keywords

Heparin - Lipase - Haemorrhage

• References

• 1 Salzman EW. Low molecular weight heparin - is small beautiful?. N Engl J Med 1986; 315: 957-959
• 2 Thomas DP. Current status of low molecular weight heparin. Thromb Haemostas 1986; 56: 241-242
• 3 Andersson L-O, Barrowcliffe TW, Holmer EA, Johnson EA, Sims GE C. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575-583
• 4 Barrowcliffe T W, Johnson EA, Eggleton CA, Kemball-Cook G, Thomas DP. Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 1979; 41: 573-583
• 5 Thomas DP. Heparin in the prophylaxis and treatment of venous thrombosis. Semin Haematol 1978; 15: 1-17
• 6 Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin and heparin. Blood 1982; 59: 1239-1245
• 7 Esquivel GO, Bergqvist D, Björk CG, Nilsson B. Comparison between commercial heparin, low-molecular-weight heparin andpentosan polysulphate on hemostasis and platelets in vivo. Thromb Res 1982; 8: 389-399
• 8 Cade JF, Buchanan MR, Boneu B, Ockelford P, Carter CJ, Cerskus AL, Hirsh J. A comparison of the antithrombotic and haemorrhagic. Effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 1984; 35: 613-625
• 9 Schmitz-Huebner U, Bünte H, Freise G, Reers B, Rüschmeyer C, Scherer R, Schulte H, van de Loo J. Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis. Klin Wochenschr 1984; 62: 349-353
• 10 Koller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick PG. Low molecular weight heparin (Kabi 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin. Thromb Haemostas 1986; 56: 243-246
• 11 Bergqvist D, Burmark US, Frisell J, Hallibook I, Lundblad B, Risberg B, Torngren S, Wallin G. Low molecular weight heparin once daily compared with conventional low dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 1986; 73: 204-208
• 12 Kakkar VV, Murray WJ G. Efficacy and safety of low-molecular-weight heparin (CY 216) in preventing postoperative venous thromboembolism: a cooperative study. Br J Surg 1985; 72: 786-791
• 13 Persson E, Nordenström J, Nilsson-Ehle P, Hagenfeldt L. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest 1985; 15: 215-220
• 14 Barrowcliffe TW, Gray E, Merton RE, Dawes J, Jennings CA, Hubbard AR, Thomas DP. Anticoagulant activities of pentosan polysulphate (Hèmoclar) due to release of hepatic triglyceride lipase (HTGL). . Thromb Haemostas 1986; 56: 202-206
• 15 Gray E, Bengtsson-Olivecrona G, Olivecrona T, Barrowcliffe TW. Anti-Xa activity of human hepatic triglyceridelipase. J Lab ClinMed 1987; 109: 653-659
• 16 Johnson EA, Paterson MS. Lead precipitation: an aid to separation of dermatan and mucokeratan sulfates from glycosaminoglycan mixtures. Anal Biochem 1986; 158: 111-116
• 17 Merton RE, Thomas DP. Experimental studies on the relative effectiveness of dermatan sulphateand heparin as antithrombotic agents. Thromb Haemostas 1987; 58: 839-842
• 18 Nilsson-Ehle P, Schotz MC. A stable radioactive substrate emulsion for the assay of lipoprotein lipase. J Lipid Res 1976; 17: 536-541
• 19 Williams SP, Barrowcliffe TW. The effects of post-heparin plasma lipases on anti-Xa clotting activity. Thromb Res 1985; 37: 371-377
• 20 Proctor RR, Rapaport SI. A partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 121-129
• 21 Thomas DP, Merton RE. A low molecular weight heparin compared with unfractionated heparin. Thromb Res 1982; 28: 343-350
• 22 Pangrazzi J, Abbadini M, Zametta M, Casu B, Donati MB. Low molecular weight heparins and bleeding. Thromb Haemostas 1985; 53: 158
• 23 Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favrean L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64-73
• 24 Brace LD, Fareed L. Heparin-induced platelet aggregation: dose/ response relationships for a low molecular weight heparin derivate (PK 10169) and its subfractions. Thromb Res 1986; 42: 769-782
• 25 Westwick J, Scully MF, Poll C, Kakkar VV. Comparison of the effects of low-molecular-weight heparin and unfractionated heparin on activation of human platelets in vitro. Thromb Res 1986; 42: 435-447
• 26 Holmer E, Lindahl U, Bäckström G, Thunberg LK, Sandberg H, Söderström G, Andersson L-O. Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for anti-thrombin. Thromb Res 1980; 18: 861-869
• 27 Van Ryn-McKenna J, Ofosu FA, Johnson EA, Hirsh J, Buchanan MR. Increased sulfation increases the bleeding side-effects of gly-cosaminoglycans. Thromb Haemostas 1987; 58: 57
• 28 Borowska A, Lauri D, Dejana E, deGaetano G, Donati MB, Pangrazzi J. Impairment of primary haemostasis by low molecular weight-heparins in rats. Br J Haematol 1988; 68: 339